Security key
604749101
Mirum Pharmaceuticals, Inc. - Common Stock (MIRM)
CUSIP: 604749101
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 60,799,281
- Total 13F shares
- 52,986,109
- Share change
- -679,657
- Total reported value
- $2,190,964,431
- Put/Call ratio
- 3835%
- Price per share
- $41.35
- Number of holders
- 204
- Value change
- -$26,045,809
- Number of buys
- 105
- Number of sells
- 74
Report period
Q4 2024
Institutions
204
Top holders
10
MIRM full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Mirum Pharmaceuticals, Inc. SEC filings
Mirum Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 604749101
Recent filing periods:
Top shareholders of MIRM - Mirum Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
11%
|
6,570,392
|
$256,245,288 | — | 30 Sep 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
7.4%
|
4,480,284
|
$174,737,642 | — | 30 Sep 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
5.7%
|
3,445,363
|
$134,369,157 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
5.5%
|
3,368,157
|
$131,358,123 | — | 30 Sep 2024 | |
| BVF INC/IL |
13F
|
Company |
5.1%
|
3,075,907
|
$119,960,373 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.1%
|
2,496,112
|
$97,348,368 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
3%
|
1,793,728
|
$69,955,392 | — | 30 Sep 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
2.6%
|
1,580,488
|
$61,639,032 | — | 30 Sep 2024 | |
| Novo Holdings A/S |
13F
|
Company |
2.5%
|
1,500,000
|
$58,500,000 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.3%
|
1,391,409
|
$54,264,951 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.1%
|
1,287,107
|
$50,197,173 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.1%
|
1,284,106
|
$50,081,000 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
936,197
|
$36,518,569 | — | 30 Sep 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.5%
|
895,690
|
$34,931,910 | — | 30 Sep 2024 | |
| Clearbridge Investments, LLC |
13F
|
Company |
1.5%
|
889,100
|
$34,674,919 | — | 30 Sep 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
1.2%
|
741,368
|
$28,913,000 | — | 30 Sep 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
1.2%
|
731,104
|
$28,513,056 | — | 30 Sep 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.1%
|
675,000
|
$26,325,000 | — | 30 Sep 2024 | |
| First Turn Management, LLC |
13F
|
Company |
1.1%
|
647,611
|
$25,256,829 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
637,967
|
$24,880,713 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1%
|
625,916
|
$24,410,729 | — | 30 Sep 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.97%
|
592,656
|
$23,569,930 | — | 30 Sep 2024 | |
| BOONE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.89%
|
543,843
|
$21,209,877 | — | 30 Sep 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.84%
|
508,475
|
$19,829,637 | — | 30 Sep 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.82%
|
499,316
|
$19,473,000 | — | 30 Sep 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.81%
|
492,723
|
$19,216,197 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.81%
|
492,409
|
$19,203,951 | — | 30 Sep 2024 | |
| CADIAN CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.78%
|
475,714
|
$18,552,846 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.77%
|
466,209
|
$18,182,151 | — | 30 Sep 2024 | |
| Prosight Management, LP |
13F
|
Company |
0.77%
|
465,825
|
$18,167,175 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.75%
|
455,564
|
$17,766,996 | — | 30 Sep 2024 | |
| AXA S.A. |
13F
|
Company |
0.7%
|
426,068
|
$16,616,652 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.6%
|
367,485
|
$14,331,915 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.54%
|
331,005
|
$12,909,195 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.54%
|
328,161
|
$12,798,279 | — | 30 Sep 2024 | |
| Penn Capital Management Company, LLC |
13F
|
Company |
0.51%
|
309,244
|
$12,091,234 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.47%
|
284,532
|
$11,096,748 | — | 30 Sep 2024 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.43%
|
260,000
|
$10,135,500 | — | 30 Sep 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.42%
|
256,779
|
$10,014,381 | — | 30 Sep 2024 | |
| NORGES BANK |
13F
|
Company |
0.41%
|
248,157
|
$9,678,123 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.4%
|
245,918
|
$9,590,802 | — | 30 Sep 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.4%
|
242,711
|
$9,465,729 | — | 30 Sep 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.38%
|
228,351
|
$8,905,689 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.37%
|
227,473
|
$8,871,447 | — | 30 Sep 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.36%
|
220,394
|
$8,595,366 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.34%
|
205,500
|
$8,014,500 | — | 30 Sep 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.31%
|
190,476
|
$7,428,564 | — | 30 Sep 2024 | |
| ARDSLEY ADVISORY PARTNERS LP |
13F
|
Company |
0.31%
|
190,000
|
$7,410,000 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.3%
|
183,344
|
$7,150,409 | — | 30 Sep 2024 | |
| NEXT CENTURY GROWTH INVESTORS LLC |
13F
|
Company |
0.27%
|
164,371
|
$6,410,469 | — | 30 Sep 2024 |
Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q4 2024
As of 31 Dec 2024,
Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) was held by
204 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,986,109 shares.
The largest 10 holders included
Frazier Life Sciences Management, L.P., JANUS HENDERSON GROUP PLC, BlackRock, Inc., BVF INC/IL, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, Novo Holdings A/S, Rock Springs Capital Management LP, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
205
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
176
Q4 2024 holders
204
Holder diff
28
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.